Neuroleptic malignant syndrome following levomepromazine discontinuation

J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):E16. doi: 10.1176/jnp.2010.22.2.247.e16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antimanic Agents / administration & dosage
  • Antimanic Agents / adverse effects
  • Antimanic Agents / therapeutic use
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Humans
  • Male
  • Methotrimeprazine / administration & dosage
  • Methotrimeprazine / adverse effects*
  • Methotrimeprazine / therapeutic use
  • Neuroleptic Malignant Syndrome / drug therapy
  • Neuroleptic Malignant Syndrome / etiology*
  • Substance Withdrawal Syndrome / etiology*
  • Valproic Acid / administration & dosage
  • Valproic Acid / adverse effects
  • Valproic Acid / therapeutic use

Substances

  • Antimanic Agents
  • Antipsychotic Agents
  • Valproic Acid
  • Methotrimeprazine